Clinical TrialID 5538
Study to Learn More About the Benefits and Side-effects of Drugs Rivaroxaban and Apixaban Compared to the Drug Warfarin for Stroke Prevention in Patients With Rapid and Irregular Heartbeat Which is Not Due to a Heart-valve Fault (Non-valvular Atrial Fibrillation) in the UK Routine Clinical Practice
NCT03847181
Atrial Fibrillation
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 5538
- Evidence Id
- 5538
- Core Evidence Id
- 5538
- Source Clinical Trial Id
- 5520
- Herb2 Clinical Trial Id
- HBCT005520
- Nct Id
- NCT03847181
- Title
- Study to Learn More About the Benefits and Side-effects of Drugs Rivaroxaban and Apixaban Compared to the Drug Warfarin for Stroke Prevention in Patients With Rapid and Irregular Heartbeat Which is Not Due to a Heart-valve Fault (Non-valvular Atrial Fibrillation) in the UK Routine Clinical Practice
- Status
- Completed
- Phase
- Study Result
- No
- Study Condition
- Atrial Fibrillation
- Study Type
- Observational
- Study Design
- Observational Model: |Time Perspective: p
- Intervention
- DRUG: Rivaroxaban (Xarelto, BAY59-7939)|DRUG: Apixaban (Eliquis)|DRUG: Warfarin
- Intervention Allocation
- Intervention Model
- Intervention Mask
- Intervention Purpose
- Gender
- All
- Age
- Adult, Older_Adult
- Enrollment
- 45164
- Outcome Measure
- Risk of intracranial hemorrhage, Intracranial hemorrhage includes intracerebral hemorrhage, subarachnoid hemorrhage, subdural and epidural hemorrhage., Retrospective analysis of data from 2012 to 2017|Risk of ischemic events, Ischemic events include ischaemic stroke / systemic embolism and myocardial infarction., Retrospective analysis of data from 2012 to 2017
- Sponsor Collaborator
- Bayer|Janssen, LP
- Funded By
- INDUSTRY
- Location
- Many facilities, Many Sites, United Kingdom
- Other Id
- 20343|EUPAS28234
- Start Date
- 2019-02-28
- Primary Completion Date
- 2020-10-31
- Completion Date
- 2020-10-31
- First Posted
- 2019-02-20
- Results First Posted
- Last Update Posted
- 2021-10-28
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT03847181
- Title Cn
- Title En
- Study to Learn More About the Benefits and Side-effects of Drugs Rivaroxaban and Apixaban Compared to the Drug Warfarin for Stroke Prevention in Patients With Rapid and Irregular Heartbeat Which is Not Due to a Heart-valve Fault (Non-valvular Atrial Fibrillation) in the UK Routine Clinical Practice
- Bilingual Status
- semi_complete